Top 5 2nd Quarter Trades of PICTON MAHONEY ASSET MANAGEMENT

Author's Avatar
insider
Aug 08, 2022
Article's Main Image

PICTON MAHONEY ASSET MANAGEMENT recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

33 YONGE STREET, SUITE 830 TORONTO, A6 M5E 1G4

As of the latest 13F report, the guru’s equity portfolio contained 851 stocks valued at a total of $2.49Bil. The top holdings were MSFT(1.60%), SWCH(1.28%), and LLY(1.17%).

According to GuruFocus data, these were PICTON MAHONEY ASSET MANAGEMENT’s top five trades of the quarter.

Cerner Corp


The guru sold out of their 530,000-share investment in NAS:CERN. Previously, the stock had a 1.81% weight in the equity portfolio. Shares traded for an average price of $93.94 during the quarter.

On 08/08/2022, Cerner Corp traded for a price of $94.92 per share and a market cap of $27.92Bil. The stock has returned 20.58% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Cerner Corp has a price-earnings ratio of 43.38, a price-book ratio of 6.88, a price-earnings-to-growth (PEG) ratio of 2.65, a EV-to-Ebitda ratio of 17.47 and a price-sales ratio of 4.46.

The price-to-GF Value ratio is 1.16, earning the stock a GF Value rank of 3.

Anaplan Inc


The guru sold out of their 670,000-share investment in NYSE:PLAN. Previously, the stock had a 1.59% weight in the equity portfolio. Shares traded for an average price of $64.77 during the quarter.

On 08/08/2022, Anaplan Inc traded for a price of $63.73 per share and a market cap of $9.59Bil. The stock has returned 16.85% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 3 out of 10.

In terms of valuation, Anaplan Inc has a price-book ratio of 38.93, a EV-to-Ebitda ratio of -51.13 and a price-sales ratio of 14.91.

The price-to-GF Value ratio is 0.83, earning the stock a GF Value rank of 9.

Switch Inc


During the quarter, PICTON MAHONEY ASSET MANAGEMENT bought 796,680 shares of NYSE:SWCH for a total holding of 951,148. The trade had a 1.07% impact on the equity portfolio. During the quarter, the stock traded for an average price of $32.29.

On 08/08/2022, Switch Inc traded for a price of $33.965 per share and a market cap of $5.13Bil. The stock has returned 40.53% over the past year.

GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 6 out of 10.

In terms of valuation, Switch Inc has a price-earnings ratio of 917.98, a price-book ratio of 14.93, a EV-to-Ebitda ratio of 26.73 and a price-sales ratio of 8.74.

The price-to-GF Value ratio is 1.61, earning the stock a GF Value rank of 1.

Zendesk Inc


The guru established a new position worth 310,200 shares in NYSE:ZEN, giving the stock a 0.92% weight in the equity portfolio. Shares traded for an average price of $98.94 during the quarter.

On 08/08/2022, Zendesk Inc traded for a price of $76.19 per share and a market cap of $9.40Bil. The stock has returned -40.76% over the past year.

GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 3 out of 10.

In terms of valuation, Zendesk Inc has a price-book ratio of 28.74, a EV-to-Ebitda ratio of -49.03 and a price-sales ratio of 6.10.

The price-to-GF Value ratio is 0.52, earning the stock a GF Value rank of 4.

Biohaven Pharmaceutical Holding Co Ltd


The guru established a new position worth 155,000 shares in NYSE:BHVN, giving the stock a 0.91% weight in the equity portfolio. Shares traded for an average price of $127.59 during the quarter.

On 08/08/2022, Biohaven Pharmaceutical Holding Co Ltd traded for a price of $147.24 per share and a market cap of $10.46Bil. The stock has returned 18.23% over the past year.

GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, Biohaven Pharmaceutical Holding Co Ltd has a EV-to-Ebitda ratio of -20.88 and a price-sales ratio of 13.49.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.

Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

Request A Demo

Learn more about GuruFocus' key features, including All-In-One Screener, backtesting, 30-year financial, stock summary page, guru trades, insider trades, excel Add-in, google sheets and much more.

GuruFocus Screeners

Related Articles